「机械飞升」18个月后，马斯克首位脑机植入者重磅发声：我重生了

Core Insights - Noland Arbaugh, the first human participant in Neuralink's brain-machine interface trial, describes his experience as life-changing, allowing him to control devices and regain a sense of purpose after being paralyzed for years [1][4][18] - Neuralink's technology features over 1,000 electrodes implanted in the motor cortex, providing a higher connectivity rate compared to competitors, and operates wirelessly, requiring charging approximately every five hours [12][8][11] - The company aims to expand its clinical trials and has plans for future projects, including restoring vision for the blind and developing robotic arms for participants [40][41][44] Company and Technology Overview - Neuralink is at the forefront of brain-machine interface technology, with a history of over 50 years in neurological research and several companies conducting limited human trials since 1998 [11] - The device implanted in Arbaugh allows him to control computers and play video games using only his thoughts, breaking records for speed and accuracy in cursor control [8][9] - The invasive nature of Neuralink's approach, while criticized, is seen as a significant advancement in the field compared to less invasive methods used by competitors [12][44] Participant Experience and Impact - Arbaugh's journey from paralysis to regaining autonomy has garnered public attention, leading to increased interest in Neuralink's trials and technology [16][45] - Since Arbaugh's surgery, additional participants have joined the trials, indicating growing momentum for Neuralink's research and development efforts [16][44] - The participant's positive outlook on the technology reflects a broader belief in the potential of tech advancements to address disabilities and improve quality of life [46][18]